Warning: The NCBI web site requires JavaScript to function. more...
Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.
Stoové MA, Fry CL, Lintzeris N.
Harm Reduct J. 2008 Apr 23;5:12.
Related citations
Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ).
Fry CL, Lintzeris N.
Addiction. 2003 Feb;98(2):171-8.
Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users.
Tucker T, Fry CL, Lintzeris N, Baldwin S, Ritter A, Donath S, Whelan G.
Addiction. 2004 Sep;99(9):1157-66.
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM, Goldberg DJ, Hutchinson SJ.
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users.
Hellard ME, Nguyen OK, Guy RJ, Jardine D, Mijch A, Higgs PG.
Aust N Z J Public Health. 2006 Dec;30(6):519-25.
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.
BMC Infect Dis. 2006 Jun 8;6:93.
Sexual activity as a risk factor for hepatitis C in Puerto Rico.
De Jesús-Caraballo J, Toro DH, Rodríguez-Pérez F, Ruiz H, Dueño MI, Alvarez M, Suárez-Pérez E; Gastroenterology Association of Puerto Rico.
Bol Asoc Med P R. 2008 Jul-Sep;100(3):15-20.
Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
Bodsworth NJ, Cunningham P, Kaldor J, Donovan B.
Genitourin Med. 1996 Apr;72(2):118-22.
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.
Hagan H, Thiede H, Des Jarlais DC.
AIDS. 2005 Oct;19 Suppl 3:S199-207. Review.
Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
Burt RD, Thiede H, Hagan H.
Drug Alcohol Depend. 2009 Dec 1;105(3):215-20. Epub 2009 Aug 31.
Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.
AIDS. 1996 Mar;10(3):311-7.
History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I.
Int J Epidemiol. 1997 Dec;26(6):1359-66.
The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T, Boonwaat L, Hailstone S, Falconer T, Lems P, Ginley T, Read V, Smith N, Levy M, Dore G, Kaldor J.
Aust N Z J Public Health. 2007 Feb;31(1):44-50.
Description of a new hepatitis C risk assessment tool.
Nguyen MT, Herrine SK, Laine CA, Ruth K, Weinberg DS.
Arch Intern Med. 2005 Sep 26;165(17):2013-8.
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X, Luo J, Bai J, Yu R.
Public Health. 2008 Oct;122(10):990-1003. Epub 2008 May 19. Review.
[The estimation of premorbid intelligence levels in French speakers].
Mackinnon A, Mulligan R.
Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43. French.
Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program.
Giuliani M, Caprilli F, Gentili G, Maini A, Lepri AC, Prignano G, Palamara G, Giglio A, Crescimbeni E, Rezza G.
Sex Transm Dis. 1997 Oct;24(9):533-7.
Hitting up in the top end: characteristics of needle exchange clients in Darwin.
Roberts C, Crofts N.
Aust N Z J Public Health. 2000 Feb;24(1):82-5.
Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF.
J Clin Virol. 2009 Mar;44(3):200-6. Epub 2009 Feb 4.
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R.
J Infect. 2000 Mar;40(2):176-83.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on